Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Papillomavirus Infections × Data Collection × Clear all

Status

Completed 7 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Specimen Handling 1 Restraint, Physical 1 Probiotics 1 Independent Medical Evaluation 1 Hepatitis A Vaccines 1 Data Collection 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01551537 2013-09-09

Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

GlaxoSmithKline

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡